We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Skinbiotherapeutics Plc | LSE:SBTX | London | Ordinary Share | GB00BF33H870 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 9.25 | 9.00 | 9.50 | 9.25 | 9.25 | 9.25 | 59,297 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 132k | -2.84M | -0.0163 | -5.67 | 16.1M |
Date | Subject | Author | Discuss |
---|---|---|---|
08/5/2018 16:06 | hmnn ... wonder if there is more to this .. with trials some way off it's making it's move much earlier than I anticipated. Not complaining though ;O) | onedayrodders | |
08/5/2018 15:55 | Buying now at 17.14p....becoming a regular riser. | bobalot | |
08/5/2018 15:18 | It's blue sky above 17.5p so a run to 22p may happen over the coming week or so imo. | bobalot | |
08/5/2018 12:42 | I've been trying to buy all morning and it won't quote me anymore than 10k. Very interesting. | shrewdmole | |
08/5/2018 11:22 | Hitting a bit of resistance at 16p. Breaking out would be interesting. | luminoso | |
07/5/2018 21:46 | Worth a read, Skin Care becoming very topical with consumers: Skin care leads strong sales growth for Estée Lauder 02-May-2018 By Simon Pitman Strong growth across all brands helped to drive an exceptionally strong quarter for The Estée Lauder Companies, with net sales growth increasing by an impressive 18%. | bobalot | |
04/5/2018 05:55 | Microbiome on show: a major focus at in-cosmetics Global03-May-2018 hTTps://www.cosmetic | parob | |
04/5/2018 00:24 | Bob, reckon that's the 3rd. time you've drawn attention to this commentary. Some might say it's a tad ott. Please stop trying so hard; I can't remotely see how your in-your-face stuff helps share price | owenmo | |
03/5/2018 20:24 | This was recently an interesting article from a broker/ analyst: SkinBioTheraputics “significantly undervalued” despite having demonstrated significant progress Northland Capital believes that SkinBio Therapeutics PLC (LON:SBTX) is “significantly undervalued” amongst its peers despite having demonstrated significant progress since its IPO almost exactly a year ago. The broker noted that, with an average market capitalisation of £73mln for the basket, SkinBio - currently valued at £13.65mln - is significantly below that level. owenmo4 May '18 - 00:24 - 1712 of 1713 (Filtered) Permanently | bobalot | |
03/5/2018 17:41 | Still looked very strong to finish level after that selling. | shrewdmole | |
03/5/2018 16:25 | Tidying up prior to Bank Holiday? | semper vigilans | |
03/5/2018 16:24 | What has happened this afternoon is the normal process of consolidation...the share price should rebound back after the sellers have been cleared imo. The mm's just dropped the share price against fairly modest sells and once cleared the up trend channel should continue after bouncing off lower support levels. | bobalot | |
03/5/2018 16:16 | Ahh shame, We were looking quite exciting for a little while there. John | 2350220 | |
03/5/2018 14:21 | Looking very strong here now. | rafboy | |
03/5/2018 12:44 | When we break 15.6 ish the next resistance is then the 16p range with support in the trend channel....looks very good. | bobalot | |
03/5/2018 12:41 | And so it keeps rising.These small daily increases should deter traders too. | parob | |
03/5/2018 09:08 | The offer is now on 15:50p as BUYING this morning is starting to look brisk: Skinbiotherapeutics PLC LON: SBTX 15.50 GBX +0.38 (2.48%) May 3, 9:00 AM GMT+1 · Disclaimer Open 15.20 High 15.50 Low 15.00 Mkt cap 18.94M P/E ratio - Div yield - Prev close 15.12 52-wk high 15.50 52-wk low 7.07 Here is a link for charts and analysis: | bobalot | |
02/5/2018 19:08 | Didn't help that Advfn didn't list it? | shrewdmole | |
02/5/2018 18:51 | Shrewdie,I don't think yesterday's RNS got the attention it deserved as focus unexpectedly switched to OPTI following US media interest. Here's a repost of Cath's latest proactive interview which was BEFORE yesterday's news.hTTps://m.youtu | parob | |
02/5/2018 18:23 | Parob I think we will be at 30p or more pre trials. Cath sounds uber positive and you can almost sense they are very deep into a possible deal already hence the doubling of the trial numbers. S | shrewdmole | |
02/5/2018 17:58 | News flow was pretty slow here for the first 6 months or so, almost non-existent, but we can look forward to plenty across all of their application areas over the coming months. | parob | |
02/5/2018 13:32 | Yes, but volatility will increase and start to accelerate the share price from this level on stock shortage imo. | bobalot | |
02/5/2018 13:09 | 15p bid the new nosebleed level for traders ... still those who exited at 14p regretting now | onedayrodders | |
02/5/2018 12:45 | ADVFN issued a BREAKOUT ALERT. TAKE A LOOK AT TODAY'S BARCHART SHARE RATING ANALYSIS: Overall Average: 96% BUY Overall Average Signal calculated from all 13 indicators. Signal Strength is a long-term measurement of the historical strength of the Signal, while Signal Direction is a short-term (3-Day) measurement of the movement of the Signal. | bobalot |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions